Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2025: 7.11

Royalty Pharma plc Interest Coverage Ratio is 7.11 for the Trailing 12 Months (TTM) ending June 30, 2025, a 787.05% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2024 was 0.80, a -72.07% change year over year.
  • Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2023 was 2.87, a -45.60% change year over year.
  • Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2022 was 5.28, a -59.32% change year over year.
  • Royalty Pharma plc Interest Coverage Ratio for the Trailing 12 Months (TTM) ending June 30, 2021 was 12.97, a 8.25% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)